Michael P Dube
Overview
Explore the profile of Michael P Dube including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
2281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karady J, Lu M, Bergstrom G, Mayrhofer T, Taron J, Foldyna B, et al.
JACC Adv
. 2024 Jun;
3(6):100968.
PMID: 38938873
Background: People with HIV (PWH) have a high burden of coronary plaques; however, the comparison to people without known HIV (PwoH) needs clarification. Objectives: The purpose of this study was...
2.
Park S, Faraci G, Ganesh K, Dube M, Lee H
J Clin Virol
. 2024 Jan;
171:105639.
PMID: 38219684
Background: Tackling HIV drug resistance is one of major challenges for ending AIDS epidemic, but the elevated expense of cutting-edge genomics hampers the advancement of HIV genotype testing for clinical...
3.
Faraci G, Park S, Love T, Dube M, Lee H
Microbiol Spectr
. 2023 Sep;
e0228523.
PMID: 37712639
HIV incidence is a key measure for tracking disease spread and identifying populations and geographic regions where new infections are most concentrated. The HIV sequence population provides a robust signal...
4.
Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing
Faraci G, Park S, Dube M, Lee H
J Clin Virol
. 2023 May;
164:105491.
PMID: 37182384
Background: Drug resistance mutation testing is a key element for HIV clinical management, informing effective treatment regimens. However, resistance screening in current clinical practice is limited in reporting linked cross-class...
5.
Morris S, Jain S, Blumenthal J, Bolan R, Dube M, Henderson P, et al.
J Acquir Immune Defic Syndr
. 2022 Sep;
91(5):453-459.
PMID: 36084200
Background: Transgender and nonbinary individuals at risk for HIV may benefit from adherence support for pre-exposure prophylaxis. Methods: Between June 2017 and September 2020, 255 transgender and nonbinary individuals received...
6.
Hassan A, Agustin H, Burke L, Kofron R, Corado K, Bolan R, et al.
J Viral Hepat
. 2022 Mar;
29(7):529-535.
PMID: 35357767
HIV pre-exposure prophylaxis (PrEP) has been associated with incident hepatitis C virus (HCV) infection in men who have sex with men (MSM) due to decreased condom use. We examined rates...
7.
Bristow C, Hassan A, Moore D, Dube M, Corado K, Chow K, et al.
Int J STD AIDS
. 2022 Mar;
33(4):397-403.
PMID: 35239448
Background: HIV PrEP effectiveness is highly dependent on adherence. High STI incidence has been reported among PrEP users. We assessed the relationship between STI incidence (CT, NG, and syphilis) and...
8.
Patel N, Blumenthal J, Dube M, Hood A, Bolan R, Morris S
LGBT Health
. 2022 Feb;
9(3):199-206.
PMID: 35196473
Despite the importance of reliable renal function estimation among the growing transgender population, research describing the variability of existing equations is scarce. Study objectives were to (1) quantify the range...
9.
Presti R, Yeh E, Williams B, Landay A, Jacobson J, Wilson C, et al.
Open Forum Infect Dis
. 2021 Dec;
8(12):ofab550.
PMID: 34888397
Background: A5350, a phase II, randomized, double-blind study, evaluated the safety and tolerability of the probiotic Visbiome Extra Strength (ES) over 24 weeks and measured effects on inflammation and intestinal...
10.
Lee P, Fields B, Liang T, Dube M, Politano S
Case Reports Hepatol
. 2021 Oct;
2021:9947213.
PMID: 34691793
species are commensal bacteria of the human oral, gut, and vaginal microbiota that are rarely identified as clinically relevant pathogens. Here, we describe a novel case of bacteremia in a...